Handel nachbörslich: 1.60 -0.03 -1.84%

MAIA Biotechnology Inc (MAIA)

Überblick Nachrichten Preisverlauf Forum Prognose

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

MAIA Biotechnology Inc (MAIA)

MAIA Biotechnology Inc Aktie (MAIA) Neueste Nachrichten

Will MAIA Biotechnology Inc. stock sustain dividend payoutsJuly 2025 Opening Moves & Risk Managed Investment Strategies - ulpravda.ru

Will MAIA Biotechnology Inc. stock deliver compounding returns2025 Fundamental Recap & AI Forecasted Entry and Exit Points - ulpravda.ru

Can MAIA Biotechnology Inc. stock deliver strong annual returnsWeekly Trade Recap & Expert Curated Trade Ideas - ulpravda.ru

MAIA Biotechnology (MAIA) director granted 24,060 options under 2021 plan - Stock Titan

MAIA Biotechnology (MAIA) director reports grant of 29,216 stock options - Stock Titan

MAIA Biotechnology (MAIA) director receives 25,206 stock options exercisable at $1.53 - Stock Titan

MAIA Biotechnology, Inc. (MAIA) reports 29,789 director stock options at $1.53 - Stock Titan

[Form 4] MAIA Biotechnology, Inc. Insider Trading Activity - Stock Titan

MAIA Biotechnology (NASDAQ: MAIA) reports 24,633 stock options grant - Stock Titan

A stock that deserves closer examination: MAIA Biotechnology Inc (MAIA) - uspostnews.com

MAIA Biotechnology, Inc. Common Stock (NYSE:MAIA) Stock Quote - FinancialContent

MAIA Biotechnology announces open market purchases by CEO, directors - MSN

MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Up 144.9% in December - MarketBeat

MAIA Biotechnology (MAIA) Price Target Decreased by 13.32% to 12.38 - MSN

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings - The Manila Times

Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 By Investing.com - Investing.com Australia

Stan Smith buys MAIA Biotechnology shares worth $69,999 By Investing.com - Investing.com Canada

Chaouki Steven M buys MAIA Biotechnology shares worth $49999 By Investing.com - Investing.com Australia

Stan Smith buys MAIA Biotechnology shares worth $69,999 - Investing.com

Louie Ngar Yee buys MAIA Biotechnology (MAIA) shares worth $99999 - Investing.com

MAIA Biotechnology Directors Increase Holdings - TradingView — Track All Markets

MAIA (MAIA) director boosts stake with 57,189-share buy and new options - Stock Titan

MAIA Biotechnology (MAIA) director reports stock purchase and new options - Stock Titan

MAIA Biotechnology (MAIA) director reports stock and option purchases - Stock Titan

MAIA Biotechnology, Inc. announced that it has received $1.289791 million in funding - marketscreener.com

Swing Trade: Why hedge funds are buying MAIA Biotechnology Inc stockJuly 2025 Movers & Safe Entry Momentum Stock Tips - moha.gov.vn

MAIA Biotechnology Earnings Notes - Trefis

Can MAIA Biotechnology Inc. stock double in next 5 yearsPortfolio Gains Report & Capital Efficiency Focused Ideas - DonanımHaber

How MAIA Biotechnology Inc. stock compares to industry benchmarksWeekly Profit Summary & AI Forecasted Entry/Exit Points - Улправда

Can MAIA Biotechnology Inc. stock maintain operating marginsJuly 2025 Intraday Action & Expert Approved Momentum Ideas - bolumsonucanavari.com

Why MAIA Biotechnology Inc. stock is upgraded to buy2025 Valuation Update & Daily Growth Stock Tips - DonanımHaber

Can MAIA Biotechnology Inc. stock deliver consistent earnings growth2025 Historical Comparison & Fast Exit/Entry Strategy Plans - Улправда

MAIA Biotechnology, Inc. (MAIA) Gets a Buy from Noble Financial - The Globe and Mail

MAIA Biotechnology announces $2.25M private placement deal - MSN

MAIA Biotechnology Announces $2.25M Private Placement Deal - TipRanks

MAIA Biotechnology (NYSE American: MAIA) details $2.25M private placement - Stock Titan

MAIA Biotechnology Announces $1.51 Million Private Placement - The Manila Times

MAIA Biotechnology, Inc. announced that it expects to receive $1.289791 million in funding - marketscreener.com

MAIA Biotechnology Announces Significant Insider Buying - TipRanks

MAIA Biotechnology, Inc. Announces Key Developments in Cancer Therapy - TradingView — Track All Markets

MAIA Biotechnology (NYSE: MAIA) starts Ateganosine Phase 3 trial and notes insider buying - Stock Titan

MAIA Biotechnology (NYSE American: MAIA) begins Phase 3 NSCLC study of telomere-targeting ateganosine - Stock Titan

MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer - Yahoo Finance

MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential - Yahoo Finance

MAIA Biotechnology Advances NSCLC Treatment with Ateganosine - TipRanks

MAIA Biotechnology, Inc. Targets $50B Immunotherapy Market with New Approach - TradingView — Track All Markets

MAIA Biotechnology (NYSE: MAIA) highlights $50B immunotherapy market in press release - Stock Titan

MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach - The Manila Times

Prepare Yourself for Liftoff: MAIA Biotechnology Inc (MAIA) - setenews.com

Director Makes Bold Move with Major Stock Purchase in MAIA Biotechnology! - TipRanks

Dir Smith Buys 13,740 ($16.4K) Of Maia Biotechnology Inc [MAIA] - TradingView — Track All Markets

Ähnlich wie MAIA